Abstract Activation of muscarinic acetylcholine receptors (mAChRs) constitutes the primary mechanism for enhancing excitability and contractility of human detrusor smooth muscle (DSM). Since the large-conductance Ca 2+
Introduction
The physiological role of the urinary bladder is to temporarily store urine and periodically facilitate its release. These functions are subserved by coordinated cyclical contraction and relaxation of detrusor smooth muscle (DSM) and the bladder outlet region [2] . Disruption of DSM function may, in part, contribute to overactive bladder (OAB) syndrome; and in some individuals, it results in bothersome and medically significant lower urinary tract symptoms, often associated with urinary incontinence [2, 1] . The prevalence of OAB increases with age and significantly impairs quality of life [9] . Muscarinic acetylcholine receptor (mAChR) activation is the primary mechanism subserving excitability and contractility of human DSM [7, 29] . A better understanding of the mechanism by which mAChRs regulate DSM function at the cellular level is of utmost importance because antimuscarinic drugs are the current mainstay of pharmacotherapy for OAB, and such agents are associated with suboptimal efficacy and substantial collateral side effects elsewhere in the body which limit their clinical utility.
Among the five subtypes of mAChRs (m 1 -m 5 ), which are classified based on molecular and pharmacological properties, the m 2 AChR and m 3 AChRs are felt to be the subtypes primarily responsible for urinary bladder excitability in both experimental animals and humans [35, 6] . Even though the m 3 AChRs are less prevalent than the m 2 AChRs, their activation is primarily responsible for the bladder contraction resulting in normal micturition as well as the involuntary bladder contractions which result in the phenotype of urinary urgency and urinary incontinence in many individuals [7, 29] . The in vitro and in vivo activation of m 3 AChRs by acetylcholine is thought to increase inositol triphosphate production, which releases Ca 2+ from the sarcoplasmic reticulum (SR), and the Ca 2+ influx that results in the contraction of human DSM [3] . It has also been reported that the activation of mAChRs with carbachol depolarizes the membrane potential in freshly isolated human DSM cells indicating that mAChRs control the membrane potential of DSM cells [31] . A study on the relative contribution of DSM cell Ca 2+ influx to mAChRmediated contraction showed significant species differences in the DSM of humans, pigs, and mice [32] . Differences between human and animal DSM excitability are well documented [25, 10, 32] . Furthermore, most of our knowledge about the electrical properties of DSM has been derived from studies on small experimental animals such as guinea pigs, rats, and rabbits [11] . Since human is the target species of interest for therapeutic intervention, studies on tissues obtained from human donors are of critical importance.
In DSM, fast localized SR Ca 2+ releases from ryanodine receptors (RyRs), also known as Ca 2+ sparks, activate the large-conductance voltage-and Ca
2+
-activated K + (K Ca 1.1) channels causing spontaneous transient outward currents (STOCs) [12, 13, 15] . K Ca 1.1 channels are key regulators of excitability and contractility in human DSM [15] . K Ca 1.1 channels maintain the cell membrane potential and generate spontaneous transient hyperpolarizations, shape the spontaneous action potentials, regulate the intracellular Ca 2+ concentration, and thus are key regulators of DSM cell excitability [25, 16, 15, 33] . Recently, our group has demonstrated that pharmacological inhibition of K Ca 1.1 channels with iberiotoxin, a selective K Ca 1.1 channel inhibitor, decreases the whole cell outward currents in freshly isolated human DSM cells [15] . In contrast, pharmacological activation of the K Ca 1.1 channels with NS1619, a selective K Ca 1.1 channel activator, increases the whole cell outward currents and K Ca 1.1 channel open probability in freshly isolated human DSM cells [16, 19] . These findings underscore the important functional role of K Ca 1.1 channels as main regulators of human DSM excitability. However, the functional link between the clinically relevant observation of mAChR activation resulting in DSM contraction and the role of the K Ca 1.1 channel are largely unknown in humans and only limited to observations in the DSM of other species [23] . Reports from studies on smooth muscle cells isolated from the airway [36] , colon [4] , and urinary bladder of non-human species [21, 23] showed variable results with respect to the activation of mAChRs and the resulting effects on the activity of the K Ca 1.1 channels, either activation or inhibition. Since considerable differences exist between species, the results obtained in animal models cannot unconditionally be extrapolated to humans. Moreover, to our knowledge, the potential existence of a functional link between mAChRs and K Ca 1.1 channels at the cellular level in human DSM has never been explored.
The principal objective of the present work was to determine if the activation of mAChRs decreases K Ca 1.1 channel activity in human DSM cells. Using the amphotericin-Bperforated whole cell and cell-attached patch-clamp techniques, combined with pharmacological tools, we found that the activation of mAChRs with carbachol leads to the inhibition of STOCs and spontaneous transient hyperpolarizations and depolarizes the membrane potential in native human DSM cells. Under the pharmacological inhibition of the major cellular Ca 2+ sources for K Ca 1.1 channel activation (with ryanodine, thapsigargin, and nifedipine), carbachol did not affect the single K Ca 1.1 channel activity or steady-state K Ca 1.1 currents. These findings suggest that in freshly isolated human DSM cells, the muscarinic effects are mediated by intracellular Ca 2+ rather than a direct effect on the K Ca 1.1 channels. The present work in humans supports and logically builds upon our recent study showing similar findings in rat DSM [23] . Because human is the target species of interest for therapeutic intervention, the present study on native human DSM provides a translational link and pharmacophysiological validation for the mAChRs regulation of K Ca 1.1 channels complementing our earlier studies on a rodent animal model [23] .
Materials and methods
Human DSM specimen collection The human DSM tissue studies were reviewed and approved by the Medical University of South Carolina Institutional Review Board (Protocol HR#16918). According to this protocol, human DSM tissues were collected upon written informed consent to participate in this study. We obtained human bladder specimens from 29 patients (23 males and 6 females, average age of 65.9± 1.5 years, 21 Caucasians, 6 African-Americans, and 2 other) undergoing cystectomy due to bladder cancer. DSM tissues were collected from a tumor-free part of the bladder. No patients had a pre-operative history of OAB. Mucosa-free DSM strips of 5-7 mm long and 2-3 mm wide were dissected from the bladder specimens and were used for the isolation of single cells.
Enzymatic isolation of human DSM single cells Human DSM single cells were freshly isolated as described previously [15, 10, 16, 19] . Briefly, 1-2 DSM strips were incubated for 20-25 min at 37°C in a pre-warmed 2-ml dissection solution (DS) supplemented with 1-mg/ml bovine serum albumin (BSA) (Sigma), 1-mg/ml papain (Worthington, Lakewood, NJ), and 1-mg/ml DL-dithiothreitol (Sigma). Next, the tissues were transferred to 2-ml of pre-warmed DS supplemented with 1-mg/ml BSA, 0.5-mg/ml collagenase (type II from Sigma), 0.5-mg/ml trypsin inhibitor (MP Biochemicals, LLC, CA), and 100 μM CaCl 2 and incubated for 12-15 min at 37°C. The digested DSM tissues were washed 3-5 times with DS supplemented with BSA. DSM tissues were gently triturated with a fire-polished Pasteur pipette to disperse DSM single cells.
Electrophysiology experiments Freshly isolated human DSM cells were used for the patch-clamp experiments. DSM cell suspension (0.2-0.5 ml) was dropped into a recording chamber, and cells were allowed to adhere to the glass bottom for ∼30 min. Then, DSM cells were washed several times with bath solution to remove cell debris and poorly adhered DSM cells. Distinct, elongated, and bright DSM cells (when viewed under phase-contrast Axiovert 40CFL microscope) with contractile phenotype were selected for the patch-clamp recordings. A system equipped with Axopatch 200B amplifier, Digidata 1322A, and pCLAMP version 10.2 software (Molecular Devices, Union City, CA) was used for the patchclamp recordings. The recorded currents were filtered with an eight-pole Bessel filter 900CT/9L8L (Frequency Devices, Inc). The patch-clamp pipettes were prepared from borosilicate glass (Sutter Instruments, Novato, CA), pulled using a Narishige PP-830 vertical puller, and were fire-polished with a Microforge MF-830 (Narishige Group, Tokyo, Japan) to give a final pipette tip resistance of 6-15 MΩ. All patch-clamp experiments were conducted at room temperature (22-23ºC) .
Perforated whole cell patch-clamp recordings We applied the amphotericin-B-perforated whole cell patch-clamp technique to record STOCs, membrane potential, spontaneous transient hyperpolarizations, and depolarization-induced steady-state K Ca 1.1 currents in DSM single cells. STOCs were measured at the holding potential of −40 mV. Depolarization-induced whole cell steady-state K Ca 1.1 currents were recorded by holding the DSM cells at −70 mV, and voltagedepolarization was applied from 0 to +80 mV in increments of 20 mV for 200 ms, and then cells were repolarized back to −70 mV. Stable outward whole cell K Ca 1.1 currents were recorded prior to (control) and after the addition of 1 μM carbachol every 1 min for 6-10 min to examine the effect of carbachol on whole cell steady-state K Ca 1.1 currents. DSM cell membrane potential with or without spontaneous transient hyperpolarizations was recorded in the current-clamp mode (I=0) of the patch-clamp technique.
Single-channel recordings Single K Ca 1.1 channel recordings were performed using the cell-attached patch-clamp technique. Single-channel recordings were conducted either in the absence or in the presence of thapsigargin (100-300 nM), a blocker of SR Ca 2+ ATPase; ryanodine (30 μM), a blocker of RyRs; and nifedipine (1 μM), a blocker of L-type voltage-gated Ca 2+ channels to eliminate the major known cellular sources of Ca 2+ for K Ca 1.1 channel activation. We applied the command voltage of −50 or −60 mV to determine the effect of carbachol on K Ca 1.1 channel open probability (NPo). This corresponds approximately to cell membrane potentials of +50 or +60 mV, respectively, assuming the cell membrane potential of 0 mV under the recording conditions of high (K + ) for both bath and pipette solutions. In experiments in which the mean K Ca 1.1 channel conductance was determined in the absence or presence of carbachol, the command potential was varied from −20 to −80 mV (V m from +20 to + 80 mVand the unitary current amplitudes determined for each voltage). Paxilline (500 nM), a selective K Ca 1.1 channel inhibitor, was added as specified.
Solutions and drugs Freshly prepared DS had (in mM) 80 monosodium glutamate, 55 NaCl, 6 KCl, 10 glucose, 10 HEPES, 2 MgCl 2 , and the pH was adjusted to 7.3 with NaOH. Physiological solution used for the perforated whole cell patch-clamp experiments contained (in mM) 134 NaCl, 6 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose, 10 HEPES, and pH was adjusted to 7.4 with NaOH. The patch-pipette solution for the perforated patch-clamp had (in mM) 110 potassium aspartate, 30 KCl, 10 NaCl, 1 MgCl 2 , 10 HEPES, 0.05 EGTA, and pH was adjusted to 7.2 with NaOH. Amphotericin-B stock solution was prepared in dimethyl sulfoxide (DMSO) and was added to the pipette solution (200 μg/ml) before the experiment and replaced every 1-2 h. Extracellular Single-channel events were analyzed over 3-5-min intervals prior to and after the addition of 1 μM carbachol. The single-channel amplitudes were calculated from all-point histograms using the Gaussian distribution function to qualify the values for closed and open states. GraphPad Prism 4.03 software (GraphPad Software, Inc., La Jolla, CA) and Corel Draw Graphic Suite X3 software (Corel Co., Mountain View, CA) were used for the statistical analyses and data presentation, respectively. Due to high degree of variability in the frequency and amplitude of STOCs in DSM cells, data were normalized with respect to control and are expressed in percentages (%). The data are expressed as mean ± SEM for the n (the number of cells) isolated from N (the number of patients). Statistical analyses were performed using the two-tailed paired Student's t test. A P value <0.05 was considered to be statistically significant.
Results

mAChR agonist carbachol inhibits STOCs in native freshly isolated human DSM cells
We examined the whole cell K Ca 1.1 currents in freshly isolated human DSM cells using the perforated patch-clamp technique, which preserves the native physiological environment of the cell, including intracellular Ca 2+ . Capacitance of human DSM cells used in the present study was 20.0±1.7 pF (n=46, N=24). Under physiological conditions, freshly isolated human DSM cells exhibit spontaneous subplasmalemmal releases of Ca 2+ via SR RyRs, known as Ca 2+ sparks, which activate K Ca 1.1 channels resulting in STOCs. Because of their iberiotoxin sensitivity, STOCs are an indication of the K Ca 1.1 channel activity in human DSM cells [15, 33] . DSM cells exhibited STOCs at a holding potential of −40 mV, which is close to DSM cell resting membrane potential recorded with microelectrodes [10, 26] . To investigate whether a functional interaction exists between the mAChRs and K Ca 1.1 channels at the cellular level in human DSM cells, we tested the effects of the mAChR agonist carbachol on STOCs. As illustrated in Fig. 1, 1 Fig. 2c ). This indicates that the mAChRs and K Ca 1.1 channels interact at the cellular level to regulate the cell membrane potential in human DSM.
To further explore the functional link between the mAChRs and K Ca 1.1 channels, we evaluated the effect of carbachol on DSM cell membrane potential in the presence of iberiotoxin (200 nM), a selective inhibitor of the K Ca 1.1 channels. As illustrated in Figs. 2d, e, under conditions of K Ca 1.1 channel pharmacological blockade with iberiotoxin, carbachol (1 μM)-induced membrane potential depolarization was eliminated (n=11, N=4; P>0.05). These results revealed that the blockade of the K Ca 1.1 channels prevented the depolarizing effect of carbachol in the human DSM cell. This observation supports that the effect of muscarinic receptor activation on DSM excitability is mediated by the K Ca 1.1 channels. mAChR agonist carbachol does not affect the depolarizationinduced whole cell steady-state K Ca 1.1 currents in the presence of thapsigargin, ryanodine, and nifedipine In the next series of experiments, we sought to explore how mAChRs activation with carbachol affects the whole cell steady-state K Ca 1.1 currents in human DSM cells. To test whether carbachol exerts direct effects on K Ca 1.1 channels by channel phosphorylation or another mechanism, or indirectly via intracellular Ca 2+ mobilization and influx of Ca
2+
, we recorded the steady-state K Ca 1.1 currents under conditions of pharmacological inhibition (with ryanodine, thapsigargin, and nifedipine) of the major known cellular sources of Ca 2+ for K Ca 1.1 channel activation. In the presence of thapsigargin (100 nM), ryanodine (30 μM), and nifedipine (1 μM), the activation of mAChRs with carbachol (1 μM) did not change the depolarization-induced steady-state K Ca 1.1 currents at all voltages from 0 to +80 mV. At the highest voltage +80 mV, the K Ca 1.1 currents were 41.3±7.6 and 43.4±9.5 pA/pF in the absence and in the presence of 1 μM carbachol, respectively (n=9, N=6; P>0.05; Fig. 3 ). The lack of carbachol-mediated effects on whole cell steady-state K Ca 1.1 currents supports the idea that carbachol does not interact directly with K Ca 1.1 channels and suggests involvement of intracellular Ca 2+ mobilization, or Ca 2+ influx induced by mAChR activation, which results in the observed indirect attenuation of K Ca 1.1 channel activity in freshly isolated human DSM cells. mAChR agonist carbachol does not change the single K Ca 1.1 channel activity in the presence of thapsigargin, ryanodine, and nifedipine To examine whether carbachol exerts any effects on single K Ca 1.1 channel activity, we conducted singlechannel experiments using the cell-attached configuration of the patch-clamp technique. The single-channel recordings were performed under conditions of pharmacological inhibition of all major cellular sources of Ca 2+ for K Ca 1.1 channel activation, the same as in the case of the voltage-step protocol-i.e., in the presence of thapsigargin (300 nM), ryanodine (30 μM), and nifedipine (1 μM). The single K Ca 1.1 channel activities in the absence (Fig. 4a) or in the presence of 1 μM carbachol (Fig. 4b ) and in the presence of both 1 μM carbachol and 500 nM paxilline (Fig. 4c) were evaluated in human DSM cells pre-treated with thapsigargin (300 nM), ryanodine (30 μM), and nifedipine (1 μM) at the V m of +50 or +60 mV. Under these experimental conditions, K Ca 1.1 channels displayed a relatively low level of average open probability (NPo) 0.0335±0.015 and unitary single-channel amplitude of 6.6±1.0 pA (n=7, N=7). The addition of 1 μM carbachol did not have any significant effects on the NP O or unitary singlechannel current amplitude. The normalized responses (fold increases over controls) in the presence of carbachol to those of controls for the NP O and unitary current amplitude were 1.34±0.40 (n=7, N=7; P>0.05; Fig. 4d ) and 0.98±0.03 (n=7, N=7; P>0.05 ; Fig 4d) , respectively. We also determined the mean single-channel conductance by varying the V m before and after the addition of 1 μM carbachol, yielding the mean single-channel conductance values of 133.3±18.4 or 136.7±22.9 pS in the absence or presence of carbachol, respectively. This result indicates that carbachol (1 μM) also did not have a significant effect on the mean single-channel conductance (n=5, N=5; P>0.05, Fig. 4f ). In all experiments in which paxilline (500 nM) was applied in the presence of carbachol, no single K Ca 1.1 channel openings were recorded (n=3, N=3; Figs. 4c, d) , confirming that the channel openings were due indeed to K Ca 1.1 channels. Here, paxilline was used instead of iberiotoxin because this K Ca 1.1 channel blocker easily crosses the cell plasma membrane, and it can reach and block K Ca 1.1 channels recorded in the cell-attached configuration.
mAChR agonist carbachol does not alter the single K Ca 1.1 channel activity in DSM cell-attached patches with all major Ca 2+ sources intact for K Ca 1.1 channel activation In the last series of experiments, the effects of carbachol (1 μM) were examined in seven cell-attached human DSM patches (N=6) at the assumed V m of +50 or +60 mV measured in the absence of ryanodine, thapsigargin, and nifedipine. The K Ca 1.1 channels displayed a low basal level of activity, NP O of 0.1159± 2+ levels (<200 nM) in the vicinity of the channels measured. In contrast, the localized Ca 2+ levels within Ca 2+ spark sites can reach 10 μM [12] , and single K Ca 1.1 channels exposed to such high levels are expected to exhibit a very high level of activity, supported by a recent finding in excised human DSM patches with elevated intracellular Ca 2+ [19] . Under the recording conditions for the cell-attached configuration, we did not observe any simultaneous openings of at least three K Ca 1.1 channels, which, by definition, are indicative of STOC generation [24, 13] . This was not surprising since we estimated the chance of recording K Ca 1.1 channels precisely at the Ca 2+ spark site to be very low. As there are ∼three active Ca 2+ spark sites per DSM cell with each spark encompassing an area of ∼15 μm 2 and a DSM cell surface area of at least ∼2,000 μm 2 , the recording of Ca 2+ spark-dependent single K Ca 1.1 activity with the cell-attached configuration can be achieved only on rare occasions (<2.25 %) [24, 18] . Thus, the most practical experimental method to assess the effects of carbachol on Ca 2+ sparkpotentiated K Ca 1.1 channels is with the perforated whole cell patch-clamp-as we have done and described in Figs. 1 and 2- indicating a net attenuation of K Ca 1.1 channel activity dependent on intracellular Ca 2+ handling but not via a direct effect.
Discussion
The present study for the first time revealed that activation of mAChRs suppresses STOCs and spontaneous transient hyperpolarizations and depolarizes human DSM cell membrane potential. Furthermore, the lack of mAChR-induced effects on single K Ca 1.1 channel properties and steady-state K Ca 1.1 currents, in the absence of the major known cellular sources of Ca 2+ for K Ca 1.1 channel activation, suggests a contribution of intracellular Ca 2+ rather than a direct effect of carbachol on the K Ca 1.1 channels in DSM cells. Thus, the present study provides novel mechanistic insight into mAChR-mediated regulation of K Ca 1.1 channels in native freshly isolated human DSM cells.
Previously, our group and other investigators demonstrated that STOCs are controlled by the SR Ca 2+ release from RyRs, [34, 27, 5, 12, 13] and humans [15] . In the present study, the amplitude and frequency of STOCs were significantly inhibited upon the activation of mAChRs with carbachol (Fig. 1) . These data support the concept that carbacholinduced inhibition of STOCs may be caused by either direct inhibition of the RyRs or by a decrease in the SR Ca 2+ stores has been demonstrated in neuroblastoma cells [28] . In addition, phosphatidylinositol 4,5-bisphosphate (PIP 2 ) may directly potentiate the K Ca 1.1 channels in DSM cells as shown previously in recombinant cells [30] . Another study on rat DSM cells, in agreement with present findings in human DSM cells, has reported that the pharmacological activation of mAChRs with carbachol leads to the inhibition of the K Ca 1.1 currents [23] . In contrast to earlier reports, here, we examined the effects of carbachol on human DSM K Ca 1.1 channels measured with the cell-attached single-channel technique under conditions of intact and inhibited major sources of Ca 2+ for K Ca 1.1 channel activation and examined how mAChR activation affected K Ca 1.1 channel-dependent STOCs, spontaneous transient hyperpolarizations, and membrane potential in freshly isolated (not-cultured) human DSM cells. Examination of the responses directly in human cells or tissues including DSM is required as the data from experimental animals does not necessarily directly translate to humans and shows interspecies differences [25] .
Previous studies demonstrated a link between mAChR activation and enhancement of DSM cell excitability. Using intracellular microelectrode recordings, mAChR activation with a higher concentration of carbachol (10 μM) caused substantial depolarization in DSM tissues of experimental animals and humans and a robust increase in action potential frequency [10] . A transient hyperpolarization followed by a sustained depolarization of membrane potential coincident with the activation of mAChRs has been reported in freshly isolated human DSM cells [31] . It has also been suggested that RyR activity can regulate the membrane potential in guinea pig DSM through the modulation of K Ca 1.1 channel activity [14] . Our group has previously shown that blocking the K Ca 1.1 channels with iberiotoxin significantly depolarizes the membrane potential of human DSM cells and suppresses the spontaneous transient hyperpolarizations [15] . The present results are consistent with those findings because 1 μM carbachol caused a small but significant depolarization of DSM cell membrane potential, and these depolarizing effects were eliminated by blocking the K Ca 1.1 channels with iberiotoxin (Figs. 2a, b) . One interpretation of these results is that both iberiotoxin and the mAChR agonist carbachol inhibit K Ca 1.1 channel activity and thus depolarize DSM cell membrane potential. Furthermore, this carbachol-induced membrane potential depolarization may subsequently activate the L-type voltagegated Ca 2+ channels and enhance the action potential firing and related phasic contractions in human DSM.
Recently, using the excised patch single-channel recordings, our group has demonstrated that the activation of K Ca 1.1 channels with NS1619 enhanced the K Ca 1.1 channel open probability without altering the mean K Ca 1.1 channel conductance in freshly isolated human DSM cells [19] . In the present work, we explored whether the activation of mAChRs with carbachol affects the single K Ca 1.1 channel properties in native freshly isolated human DSM cells using the cell-attached single-channel recording technique. Under conditions of pharmacological inhibition of all major cellular sources of Ca 2+ for (Fig. 4) . These results suggest a role of intracellular Ca 2+ in the mAChR-mediated regulation of K Ca 1.1 channels in human DSM cells. Our data further demonstrated that mAChR activation with carbachol did not alter the depolarization-evoked steady-state K Ca 1.1 currents under conditions of pharmacological inhibition of the major cellular sources of Ca 2+ for K Ca 1.1 channel activation (Fig. 3) , consistent with the results of the single K Ca 1.1 channel recordings (Fig. 4) . It has been demonstrated that mAChR-mediated Ca 2+ mobilization due to Ca 2+ influx and Ca 2+ release is the key event in mediating the contractions of DSM in humans, pigs, and mice [32] . In the present study, carbachol had a significant inhibitory effect on STOCs and cell membrane potential in the presence of all cellular sources of Ca 2+ for K Ca 1.1 channel activation. However, carbachol did not have any direct effects on NP O , singlechannel conductance, or steady-state K Ca 1.1 currents under conditions of pharmacological inhibition of the major cellular sources of Ca 2+ for K Ca 1.1 channel activation (Figs. 3 and 4 ). In addition, under the experimental conditions of intact intracellular Ca 2+ sources favoring the recording of low probability of opening of K Ca 1.1 channels-indicative of low Ca 2+ levels in the range of 100-200 nM in the vicinity of the channelscarbachol (1 μM) did not change the NP O or unitary singlechannel amplitude. These findings are similar to the results obtained in the presence of the blockers of the Ca 2+ sources. Furthermore, the Ca 2+ dependency for the activation of K Ca 1.1 channels determines that the effects of Ca 2+ are stimulatory only at relatively high levels of Ca 2+ reaching micromolar concentrations [8, 22] . At lower Ca 2+ concentrations (<300 nM), the half-maximum constants for K Ca 1.1 channel activation remain unchanged [8, 22] . As mAChR activation does not increase the global Ca 2+ concentrations at the steadystate levels-at which we determined the effects on singlechannel activities and voltage-evoked steady-state currentsabove approximately 300 nM [20] , we did not detect any increases in K Ca 1.1 channel activities that could be solely due to the increase in intracellular Ca 2+ alone. Our data support the concept that mAChRs and K Ca 1.1 channel activities are functionally coupled to intracellular Ca 2+ levels, which are dependent on the L-type voltage-gated Ca 2+ channels, SR Ca 2+ -pumps, and RyRs in DSM cells. When localized Ca 2+ levels reach high concentrations achieved during Ca 2+ sparks, they activate STOCs. Furthermore, the present findings in human DSM cells are consistent with a recent study, which reported that mobilization of intracellular Ca 2+ is critical in mAChR-mediated K Ca 1.1 channel regulation in rat DSM cells [23] . It has also been suggested that protein kinase-C (PKC) regulatory pathways are involved in DSM function [2, 7, 17] . The m 3 AChR activation leads to diacylglycerol production, which activates PKC. PKC may cause direct inhibition of the SR Ca 2+ pumps and/or RyRs, collectively resulting in the suppression of STOCs as shown in the present study.
In conclusion, our results for the first time reveal that pharmacological activation of mAChRs with carbachol inhibits STOCs, suppresses spontaneous transient hyperpolarizations, and depolarizes the cell membrane potential in native freshly isolated human DSM cells. We provide evidence that the carbachol inhibitory effect on the K Ca 1.1 channel in human DSM cells involves intracellular Ca
2+
. Collectively, these findings strongly suggest that there is a functional indirect link between the mAChRs and K Ca 1.1 channels in human DSM cells.
